“The Committee recommends that the Ministry take proactive steps to correspond with the 16th Finance Commission and accordingly develop a plan for adequate fund allocation and timely release for the next five years, accelerating AYUSH’s growth.”It also strongly recommended consolidating all AYUSH drug-related standard-setting processes under a single authoritative body – an independent drug controller of AYUSH – in alignment with the Drugs and Cosmetics Act, 1940, and its associated rules.“To achieve this, the Ministry should establish a streamlined and inclusive mechanism that actively involves stakeholders in the development of pharmacopoeial standards, ensuring greater efficiency and uniformity,” the Committee said.It also suggested that going forward, communication should be made with first-world countries like the UK and the US to promote AYUSH among the Indian diaspora and their native citizens.The Committee realizes the potential of promoting AYUSH-related healthcare travel to India. Accordingly, the Ministry must devise strategies to vigorously promote the AYUSH system of medicine in international markets, support investment, and exchange exports to boost Ayush products in the global market.Noting that nearly 271 research projects have been completed during the last five years, the report observed that documenting findings in a comprehensive final report and publishing results in peer-reviewed journals and conferences is essential to disseminating knowledge.“The Committee recommends to the Ministry to ensure compliance with ethical, regulatory, and funding requirements, including proper acknowledgements that are crucial for maintaining accountability and credibility in the Ayurvedic System of Medicine,” it said.
Source link
